Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9FJX

Crystal structure of human CRBN-DDB1 in complex with Lenalidomide

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsDIAMOND BEAMLINE I04-1
Synchrotron siteDiamond
BeamlineI04-1
Temperature [K]100
Detector technologyPIXEL
Collection date2017-10-23
DetectorDECTRIS EIGER2 XE 9M
Wavelength(s)0.9159
Spacegroup nameP 21 21 21
Unit cell lengths71.673, 129.068, 198.446
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution20.150 - 2.000
R-factor0.1978
Rwork0.196
R-free0.23190
Structure solution methodMOLECULAR REPLACEMENT
RMSD bond length0.008
RMSD bond angle1.000
Data reduction softwareDIALS
Data scaling softwareAimless (0.5.32)
Phasing softwarePHASER
Refinement softwareBUSTER (2.10.4 (26-JUL-2023))
Data quality characteristics
 OverallInner shellOuter shell
Low resolution limit [Å]49.61049.6102.030
High resolution limit [Å]2.00010.9502.000
Rmerge0.1140.0322.123
Rmeas0.1230.0342.324
Rpim0.0460.0130.928
Total number of observations900114630438719
Number of reflections1249008906121
<I/σ(I)>9.738.40.9
Completeness [%]99.999.199.9
Redundancy7.27.16.3
CC(1/2)0.9980.9990.309
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP8.22910.8 microliter of CRBN-DDB1 complex at 25 mg/mL (including 1 mM compound and 2 % DMSO final) plus 0.8 microliter of a crystallisation solution consisting of 0.1 M Hepes pH 8.2, 0.2 M NaCl and 10-16 % PEG Smear Medium, plus 0.2 microliter of seeds (established from the same conditions), against 500 microliter of crystallisation solution.

246031

PDB entries from 2025-12-10

PDB statisticsPDBj update infoContact PDBjnumon